Investigation of Pediatric Anemia in the Commonwealth of the Northern Mariana Islands

Tiffany F Lin1,2,3, James N Huang4,5, Haley L Cash6

  • 1UCSF Benioff Children's Hospital, San Francisco, USA. tiffany.lin@ucsf.edu.

Insights

Pediatric anemia prevalence in the Northern Mariana Islands is 8.0%, with iron deficiency being a key concern. Thalassemia variants were also identified, highlighting the need for targeted public health interventions.

Area of Science:

  • Pediatrics
  • Public Health
  • Hematology

Background:

  • Pediatric anemia poses a significant global health challenge, particularly in island nations.
  • Understanding anemia prevalence and causes in the Commonwealth of the Northern Mariana Islands (CNMI) is crucial for targeted interventions.

Purpose of the Study:

  • To determine the prevalence and etiological factors of pediatric anemia in the CNMI.
  • To provide data for future public health strategies and improve pediatric care.

Main Methods:

  • A retrospective chart review of 1483 pediatric patients (up to 19 years) from 2014-2015 in the CNMI.
  • Inclusion criteria: well-child care visits with hemoglobin or hematocrit testing.
  • Data collected: lab values, diagnoses, treatments, ethnicity, follow-up results.

Main Results:

  • Overall anemia prevalence was 8.0% (95% CI: 5.4-10.7).
  • Among 9-18 month olds, anemia prevalence was 5.5% (95% CI: 2.6-8.4).
  • 55.2% of patients treated with iron showed documented improvement; thalassemia variants were identified in 10 patients.

Conclusions:

  • Pediatric anemia prevalence in the CNMI is lower than in other Pacific Island nations and comparable to the US.
  • Iron deficiency and thalassemia are significant etiological factors requiring public health attention.
  • Further studies and interventions are needed to address pediatric anemia in the CNMI.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
576
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
1.2K